Geographic variation exists in stimulant drug use in U.S.

08/11/2013 |

U.S. researchers looked at 24.1 million stimulant prescriptions for insured and uninsured attention-deficit/hyperactivity disorder patients, and found that about 2.5% of youths aged 17 and younger and 6% of those aged 18 and older received stimulant drugs in March 2008. Wide variation in treatment prevalence among states and counties indicate disparities between clinical practice guidelines and actual practice, according to the study authors. The findings appear in the journal Psychiatric Services.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Health Plan Administration, Payor Relations and Contracting
St. Charles Health System
Bend, OR
Compliance Sr Mgr
Thousand Oaks, CA
Senior Counsel, Regulatory (FDA)
San Diego , CA
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA